Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Inivata Ltd.
Deal-making and financing activities are on the rise for liquid biopsy diagnostic products in 2021 despite questions remaining around whether the technology can unseat standard-of-care biomarker and imaging tests.
Inivata will remain a separate liquid biopsy division alongside NeoGenomics’ growing clinical, pharma and informatics divisions.
AACR 2020: Liquid Biopsy Company Guardant Health Presents Colorectal Cancer Data, Outlines Plans For Regulatory Approval
Guardant Health presented new clinical data at this week’s American Association for Cancer Research conference and outlined its growth plans as cancer testing volumes recover after the pandemic.
The Top 5 Market Intel Stories Of 2019: A Mixed Bag Of Hemodialysis, Robotics, Ophthalmology, Femtech And Liquid Biopsy
A look back at Medtech Insight’s five most-read Market Intelligence features of 2019 reveals a diverse mix of interests among our readers – hemodialysis, robotic surgeries, ophthalmic surgical solutions, liquid biopsy and digital technologies that seek to improve women's health.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing